Literature DB >> 23878360

3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization.

Michael Quentin1, Lars Schimmöller, Christian Arsov, Robert Rabenalt, Gerald Antoch, Peter Albers, Dirk Blondin.   

Abstract

BACKGROUND: To estimate potential malignant lesions within the prostate gland, the usage of a scoring system has recently been proposed by a European consensus meeting.
PURPOSE: To prospectively investigate a scoring system for functional prostate magnetic resonance imaging (MRI) using in-bore MR-guided prostate biopsy at 3-T.
MATERIAL AND METHODS: Prostate MRI examinations of 59 patients (between February 2011 and May 2012) with no known prostate cancer, elevated prostate specific antigen (PSA) level, and unsuspicious digital rectal examination were included in the study. In each patient up to three lesions were defined and scored using a 5-point scoring system for each MR sequence (T2-weighted images, diffusion-weighted imaging, dynamic contrast-enhanced imaging). Following MRI-guided in-bore biopsy these lesions were correlated to the histopathological findings.
RESULTS: A total number of 144 lesions were defined in 59 patients. In 28 patients (51 lesions) MR-guided in-bore biopsy was positive for tumor (Gleason grade 6 or higher). A cut-off limit of 10 or more points in summation of the individual scores of all three sequences was used, leading to a 90% sensitivity, 63% specificity, 58% positive predictive value, and 92% negative predictive value.
CONCLUSION: A simple 5-point scoring system of functional prostate MRI achieves excellent sensitivity and moderate specificity for directing 3-T-guided prostate biopsy relative to the histopathological findings.

Entities:  

Keywords:  3-T MRI; Prostate cancer; in-bore MR-guided biopsy at 3-T; scoring

Mesh:

Substances:

Year:  2013        PMID: 23878360     DOI: 10.1177/0284185113492972

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers.

Authors:  Kareem K Elfatairy; Christopher P Filson; Martin G Sanda; Adeboye O Osunkoya; Sherif G Nour
Journal:  Radiol Imaging Cancer       Date:  2020-09-25

2.  Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).

Authors:  Daniel Junker; Thomas R W Herrmann; Markus Bader; Jasmin Bektic; Gregor Henkel; Stephan Kruck; Markus Sandbichler; David Schilling; Georg Schäfer; Udo Nagele
Journal:  World J Urol       Date:  2015-07-01       Impact factor: 4.226

3.  Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.

Authors:  Zhao-Yan Feng; Liang Wang; Xiang-De Min; Shao-Gang Wang; Guo-Ping Wang; Jie Cai
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

4.  Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients.

Authors:  Kai Zhang; Zhipeng Zhang; Ming Liu; Gang Zhu; Monique J Roobol
Journal:  Transl Androl Urol       Date:  2020-04

5.  Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.

Authors:  Susanne Tewes; Nikolaj Mokov; Dagmar Hartung; Volker Schick; Inga Peters; Peter Schedl; Stefanie Pertschy; Frank Wacker; Götz Voshage; Katja Hueper
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.